• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Refining the structure and content of clinical genomic reports.优化临床基因组报告的结构与内容。
Am J Med Genet C Semin Med Genet. 2014 Mar;166C(1):85-92. doi: 10.1002/ajmg.c.31395. Epub 2014 Mar 10.
2
Criteria for reporting incidental findings in clinical exome sequencing - a focus group study on professional practices and perspectives in Belgian genetic centres.临床外显子测序中偶然发现报告标准 - 比利时遗传中心专业实践和观点的焦点小组研究。
BMC Med Genomics. 2019 Aug 20;12(1):123. doi: 10.1186/s12920-019-0561-0.
3
A commentary on the promise of whole-exome sequencing in medical genetics.医学遗传学中全外显子组测序前景述评。
J Hum Genet. 2014 Mar;59(3):117-8. doi: 10.1038/jhg.2014.7. Epub 2014 Feb 6.
4
Implementing individualized medicine into the medical practice.将个性化医疗应用于医疗实践。
Am J Med Genet C Semin Med Genet. 2014 Mar;166C(1):15-23. doi: 10.1002/ajmg.c.31387. Epub 2014 Mar 10.
5
The promise of whole-exome sequencing in medical genetics.全外显子组测序在医学遗传学中的应用前景。
J Hum Genet. 2014 Jan;59(1):5-15. doi: 10.1038/jhg.2013.114. Epub 2013 Nov 7.
6
The patient with 41 reports: Analysis of laboratory exome sequencing reporting of a "virtual patient".患者 41 号报告:对“虚拟患者”的实验室外显子组测序报告的分析。
Genet Med. 2022 Jun;24(6):1306-1315. doi: 10.1016/j.gim.2022.03.003. Epub 2022 Apr 7.
7
ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).美国医学遗传学与基因组学学会(ACMG)关于临床外显子组和基因组测序中次要发现报告的ACMG SF v3.1清单:一项政策声明
Genet Med. 2022 Jul;24(7):1407-1414. doi: 10.1016/j.gim.2022.04.006. Epub 2022 Jun 17.
8
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.临床外显子组和基因组测序中次要发现报告的建议,2016年更新版(美国医学遗传学与基因组学学会次要发现v2.0):美国医学遗传学与基因组学学会政策声明
Genet Med. 2017 Feb;19(2):249-255. doi: 10.1038/gim.2016.190. Epub 2016 Nov 17.
9
Incidental variants are critical for genomics.偶然变异对于基因组学至关重要。
Am J Hum Genet. 2013 May 2;92(5):648-51. doi: 10.1016/j.ajhg.2013.04.001.
10
Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease.用于检测遗传性疾病中胚系变异的临床全外显子组和全基因组测序的开发与验证
Arch Pathol Lab Med. 2017 Jun;141(6):798-805. doi: 10.5858/arpa.2016-0622-RA. Epub 2017 Mar 31.

引用本文的文献

1
Improving the communication of multifactorial cancer risk assessment results for different audiences: a co-design process.改善针对不同受众的多因素癌症风险评估结果的沟通:一个协同设计过程。
J Community Genet. 2024 Oct;15(5):499-515. doi: 10.1007/s12687-024-00729-4. Epub 2024 Sep 25.
2
Determinants of targeted cancer therapy use in community oncology practice: a qualitative study using the Theoretical Domains Framework and Rummler-Brache process mapping.社区肿瘤学实践中靶向癌症治疗应用的决定因素:一项使用理论领域框架和鲁姆勒-布拉奇流程映射的定性研究
Implement Sci Commun. 2023 Jun 12;4(1):66. doi: 10.1186/s43058-023-00441-3.
3
A personalized genomic results e-booklet, co-designed and pilot-tested by families.一本由家庭共同设计并进行试点测试的个性化基因组结果手册。
PEC Innov. 2022 Apr 16;1:100039. doi: 10.1016/j.pecinn.2022.100039. eCollection 2022 Dec.
4
Investigating the presentation of uncertainty in an icon array: A randomized trial.探究图标阵列中不确定性的呈现方式:一项随机试验。
PEC Innov. 2022 Dec;1:None. doi: 10.1016/j.pecinn.2021.100003.
5
Co-design, implementation, and evaluation of plain language genomic test reports.通俗易懂的基因组检测报告的协同设计、实施与评估。
NPJ Genom Med. 2022 Oct 22;7(1):61. doi: 10.1038/s41525-022-00332-x.
6
A comprehensive genomic reporting structure for communicating all clinically significant primary and secondary findings.用于传达所有具有临床意义的原发性和继发性发现的全面基因组报告结构。
Hum Genet. 2022 Dec;141(12):1875-1885. doi: 10.1007/s00439-022-02466-5. Epub 2022 Jun 23.
7
Choices, attitudes, and experiences of genetic screening in Latino/a and Ashkenazi Jewish individuals.拉丁裔和阿什肯纳兹犹太个体在基因筛查方面的选择、态度及经历。
J Community Genet. 2020 Oct;11(4):391-403. doi: 10.1007/s12687-020-00464-6. Epub 2020 May 7.
8
Recommendations for designing genetic test reports to be understood by patients and non-specialists.向患者和非专业人士解读遗传检测报告的设计建议。
Eur J Hum Genet. 2020 Jul;28(7):885-895. doi: 10.1038/s41431-020-0579-y. Epub 2020 Feb 5.
9
Molecular profiling for precision cancer therapies.精准肿瘤治疗的分子谱分析。
Genome Med. 2020 Jan 14;12(1):8. doi: 10.1186/s13073-019-0703-1.
10
First Responder to Genomic Information: A Guide for Primary Care Providers.基因组信息的第一响应者:初级保健提供者指南。
Mol Diagn Ther. 2019 Aug;23(4):459-466. doi: 10.1007/s40291-019-00407-z.

本文引用的文献

1
Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.临床测序探索研究联盟中基因组序列数据中可操作基因的识别的过程和初步结果。
Genet Med. 2013 Nov;15(11):860-7. doi: 10.1038/gim.2013.133. Epub 2013 Oct 24.
2
A survey of informatics approaches to whole-exome and whole-genome clinical reporting in the electronic health record.电子健康记录中全外显子组和全基因组临床报告的信息学方法调查。
Genet Med. 2013 Oct;15(10):824-32. doi: 10.1038/gim.2013.120. Epub 2013 Sep 26.
3
Actionable, pathogenic incidental findings in 1,000 participants' exomes.1000 名参与者外显子组中的可操作、致病性偶然发现。
Am J Hum Genet. 2013 Oct 3;93(4):631-40. doi: 10.1016/j.ajhg.2013.08.006. Epub 2013 Sep 19.
4
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.ACMG 临床外显子组和基因组测序中偶然发现报告的推荐标准。
Genet Med. 2013 Jul;15(7):565-74. doi: 10.1038/gim.2013.73. Epub 2013 Jun 20.
5
Effective communication of molecular genetic test results to primary care providers.向初级保健提供者有效传达分子遗传学检测结果。
Genet Med. 2013 Jun;15(6):444-9. doi: 10.1038/gim.2012.151. Epub 2012 Dec 6.
6
A report template for molecular genetic tests designed to improve communication between the clinician and laboratory.一份旨在改善临床医生与实验室之间沟通的分子遗传学检测报告模板。
Genet Test Mol Biomarkers. 2012 Jul;16(7):761-9. doi: 10.1089/gtmb.2011.0328. Epub 2012 Jun 25.
7
Good laboratory practices for molecular genetic testing for heritable diseases and conditions.遗传性疾病和病症分子遗传学检测的良好实验室规范。
MMWR Recomm Rep. 2009 Jun 12;58(RR-6):1-37; quiz CE-1-4.
8
Clinician perspectives about molecular genetic testing for heritable conditions and development of a clinician-friendly laboratory report.临床医生对遗传性疾病分子基因检测的看法以及一份对临床医生友好的实验室报告的制定。
J Mol Diagn. 2009 Mar;11(2):162-71. doi: 10.2353/jmoldx.2009.080130. Epub 2009 Feb 5.
9
ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007.美国医学遗传学与基因组学学会(ACMG)关于序列变异解读和报告标准的建议:2007年修订版
Genet Med. 2008 Apr;10(4):294-300. doi: 10.1097/GIM.0b013e31816b5cae.
10
Clinical laboratory reports in molecular pathology.分子病理学中的临床实验室报告。
Arch Pathol Lab Med. 2007 Jun;131(6):852-63. doi: 10.5858/2007-131-852-CLRIMP.

优化临床基因组报告的结构与内容。

Refining the structure and content of clinical genomic reports.

作者信息

Dorschner Michael O, Amendola Laura M, Shirts Brian H, Kiedrowski Lesli, Salama Joseph, Gordon Adam S, Fullerton Stephanie M, Tarczy-Hornoch Peter, Byers Peter H, Jarvik Gail P

出版信息

Am J Med Genet C Semin Med Genet. 2014 Mar;166C(1):85-92. doi: 10.1002/ajmg.c.31395. Epub 2014 Mar 10.

DOI:10.1002/ajmg.c.31395
PMID:24616401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4077592/
Abstract

To effectively articulate the results of exome and genome sequencing we refined the structure and content of molecular test reports. To communicate results of a randomized control trial aimed at the evaluation of exome sequencing for clinical medicine, we developed a structured narrative report. With feedback from genetics and non-genetics professionals, we developed separate indication-specific and incidental findings reports. Standard test report elements were supplemented with research study-specific language, which highlighted the limitations of exome sequencing and provided detailed, structured results, and interpretations. The report format we developed to communicate research results can easily be transformed for clinical use by removal of research-specific statements and disclaimers. The development of clinical reports for exome sequencing has shown that accurate and open communication between the clinician and laboratory is ideally an ongoing process to address the increasing complexity of molecular genetic testing.

摘要

为了有效地阐述外显子组和基因组测序的结果,我们完善了分子检测报告的结构和内容。为了传达一项旨在评估外显子组测序在临床医学中应用的随机对照试验的结果,我们制定了一份结构化的叙述性报告。在遗传学和非遗传学专业人员的反馈下,我们制定了单独的针对特定指征和偶然发现的报告。标准检测报告要素辅以针对研究的特定语言,突出了外显子组测序的局限性,并提供了详细的结构化结果和解释。我们为传达研究结果而制定的报告格式,通过去除特定于研究的陈述和免责声明,可轻松转换为临床使用。外显子组测序临床报告的制定表明,临床医生和实验室之间准确、开放的沟通理想情况下是一个持续的过程,以应对分子基因检测日益增加的复杂性。